Loading...
Sipuleucel-T and Androgen Receptor-Directed Therapy for Castration-Resistant Prostate Cancer: A Meta-Analysis
New treatments, such as sipuleucel-T and androgen receptor- (AR-) directed therapies (enzalutamide (Enz) and abiraterone acetate (AA)), have emerged and been approved for the management of castration-resistant prostate cancer (CRPC). There are still debates over their efficacy and clinical benefits....
Na minha lista:
Udgivet i: | J Immunol Res |
---|---|
Main Authors: | , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Hindawi Publishing Corporation
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5183769/ https://ncbi.nlm.nih.gov/pubmed/28058266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4543861 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|